Zentalis Pharmaceuticals proposes underwritten public offering of shares
Zentalis Pharmaceuticals (ZNTL) announces a proposed underwritten public offering, with no further terms, pricing, or size provided in the feed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.